201 related articles for article (PubMed ID: 18643758)
1. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan.
Umemura T; Tanaka E; Kiyosawa K; Kumada H;
Clin Infect Dis; 2008 Sep; 47(5):e52-6. PubMed ID: 18643758
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.
Hui CK; Cheung WW; Zhang HY; Au WY; Yueng YH; Leung AY; Leung N; Luk JM; Lie AK; Kwong YL; Liang R; Lau GK
Gastroenterology; 2006 Jul; 131(1):59-68. PubMed ID: 16831590
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
[TBL] [Abstract][Full Text] [Related]
5. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the mortality of pediatric fulminant hepatic failure in relation to hepatitis B virus infection.
Chan PC; Chen HL; Kong MS; Huang FC; Lee HC; Lin CC; Liu CC; Lee IH; Wu TC; Wu SF; Ni YH; Hsu HY; Chang MH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1223-7. PubMed ID: 16048570
[TBL] [Abstract][Full Text] [Related]
7. [Demographic and clinical features, diagnosis and treatment of fulminant hepatitis induced by HBV infection in Japan].
Mochida S
Nihon Rinsho; 2011 May; 69 Suppl 4():446-52. PubMed ID: 22096959
[No Abstract] [Full Text] [Related]
8. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of fulminant hepatic failure in previously unrecognized HBsAg carriers with acute hepatitis independent of etiology.
Chu CM; Liaw YF
Infection; 2005 Jun; 33(3):136-9. PubMed ID: 15940414
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the clinical features of and responsive factors on the prognosis in patients with fulminant hepatic failure].
Zhang L; Han F; Wu D; Zhang D; Feng GH
Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):614-7. PubMed ID: 20825718
[TBL] [Abstract][Full Text] [Related]
11. Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system.
Tsai SH; Chang HM; Hsieh CB; Chao YC; Hsieh TY
J Infect; 2006 Jul; 53(1):e19-23. PubMed ID: 16269182
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the entire nucleotide sequence of hepatitis B causing consecutive cases of fatal fulminant hepatitis in Miyagi Prefecture Japan.
Nagasaki F; Ueno Y; Niitsuma H; Inoue J; Kogure T; Fukushima K; Kobayashi K; Shimosegawa T
J Med Virol; 2008 Jun; 80(6):967-73. PubMed ID: 18428142
[TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy for hepatitis B virus associated hepatic failure.
Wang YM; Tang YZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
18. [Fulminant hepatic failure by hepatitis B virus in a patient with human immunodeficiency virus infection: report of one case].
Sagredo S; Mancilla C; Estuardo N; Poniachik J
Rev Med Chil; 2011 Oct; 139(10):1336-9. PubMed ID: 22286734
[TBL] [Abstract][Full Text] [Related]
19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
20. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
